Prot #AT-03A-001: A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of AT-527 in Subjects with Moderate COVID-19

Project: Research project

Project Details

StatusActive
Effective start/end date7/7/207/7/23

Funding

  • Quintiles, Inc. (Prot #AT-03A-001)
  • Atea Pharmaceuticals, Inc. (Prot #AT-03A-001)